1.646.889.1200|info@lifescipublicrelations.com

Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

//Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

The French company OSE Immunotherapeutics has signed a partnership to use artificial intelligence to develop treatments for tumors that don’t respond to checkpoint inhibitor drugs.

By | 2019-03-27T10:19:36-04:00 March 27th, 2019|News|Comments Off on Artificial Intelligence Could Beat Tumors Resistant to Immunotherapy

About the Author:

Related Posts

LifeSci Public Relations

LifeSci Public Relations LLC is a corporate communications and public relations firm helping clients engage their corporate audiences and achieve their business objectives via a broad array of traditional, social and digital media tools.